Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Cash & Equivalents	1.5	1.27	0.92	12.36	29.13	6.42
Short-Term Investments	14.53	18.65	22.93	17.33	6.6	2.64
Cash & Short-Term Investments	16.03	19.92	23.84	29.69	35.73	9.06
Cash Growth	-22.73%	-16.44%	-19.68%	-16.91%	294.47%	55.04%
Other Receivables	-	0.17	0.27	0.05	-	-
Receivables	-	0.17	0.27	0.05	-	-
Prepaid Expenses	1.42	1.27	1.24	0.47	0.28	0.31
Total Current Assets	17.45	21.36	25.36	30.2	36	9.37
Property, Plant & Equipment	0.2	0.23	0.17	0.21	0.25	0.05
Other Long-Term Assets	-	-	-	-	-	0.03
Total Assets	17.65	21.59	25.52	30.41	36.26	9.45
Accounts Payable	0.28	0.53	0.21	0.27	0.14	0.23
Accrued Expenses	1.75	1.95	1.77	1.73	1.1	0.9
Current Portion of Leases	0.04	0.03	0.05	0.05	0.04	0.06
Total Current Liabilities	2.07	2.5	2.03	2.04	1.27	1.19
Long-Term Leases	0.17	0.2	0.12	0.18	0.22	-
Total Liabilities	2.24	2.7	2.15	2.21	1.49	1.19
Common Stock	0.33	0.32	0.31	0.31	0.3	0.24
Additional Paid-In Capital	265.25	260.43	252.22	247.12	239.93	200.35
Retained Earnings	-248.98	-240.75	-228.2	-218.39	-204.79	-191.84
Treasury Stock	-	-0.01	-	-	-	-
Total Common Equity	16.6	20	24.34	29.05	35.44	8.76
Minority Interest	-1.18	-1.11	-0.97	-0.85	-0.67	-0.5
Shareholders' Equity	15.41	18.89	23.37	28.2	34.77	8.26
Total Liabilities & Equity	17.65	21.59	25.52	30.41	36.26	9.45
Total Debt	0.21	0.23	0.18	0.22	0.26	0.06
Net Cash (Debt)	15.82	19.69	23.67	29.47	35.47	9
Net Cash Growth	-22.88%	-16.80%	-19.67%	-16.92%	294.01%	54.10%
Net Cash Per Share	0.49	0.62	0.76	0.97	1.24	0.40
Filing Date Shares Outstanding	32.92	32.19	31.7	30.92	30.13	26.08
Total Common Shares Outstanding	32.82	32.19	31.15	30.91	30.05	24.25
Working Capital	15.38	18.86	23.33	28.16	34.73	8.18
Book Value Per Share	0.51	0.62	0.78	0.94	1.18	0.36
Tangible Book Value	16.6	20	24.34	29.05	35.44	8.76
Tangible Book Value Per Share	0.51	0.62	0.78	0.94	1.18	0.36

Updated Sep 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q